All EU safety alerts

—EMA

Arti-Cell Forte / RenuTend: quality defect

Quality defectMedicine safety communications

—EMA

Ozempic / Victoza: medicine shortage

Medicine shortageMedicine safety communications

—EMA

Voxzogo: change in dosing recommendation

Change in dosing recommendationMedicine safety communications

—EMA

Pegasys: medicine shortage

Medicine shortageMedicine safety communications